References
- The hypertensive disorders of pregnancy. World Health Organization Technical Report Series 758. Geneva: World Health Organization, 1987.
- Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic systems in preeclampsia and eclampsia. Br Med J 1971; 2: 12–16.
- Estelles A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989; 74: 1332–8.
- Thornton JG, Molloy BJ, Vinall PS, Philips PR, Hughes R, Davies JA. A prospective study of haemostatic tests at 28 weeks gestation as predictors of preeclampsia and growth retardation. Thromb Haemost 1989; 61: 243–5.
- Schjetlein R, Haugen G, Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997; 76: 541–6.
- Schjetlein R, Haugen G, Sandset PM, Wisloff F. Reduced C4b-binding protein in preeclampsia. Thromb Res 1987; 85: 153–8.
- Bjerkedal T, Bakketeig L, Lehmann EH. Percentiles of birth weights of single, live births at different gestational periods. Acta Pædiatr Scand 1973; 62: 449–57.
- Østergaard PB, Beck TC, Ørsted H, Svendsen A, Nordfang O, Sandset PM et al. An enzyme linked immunosorption assay for tissue factor pathway inhibitor. Thromb Res 1997; 87: 447–59.
- Kleinbaum DG, Kopper LL, Morgenstern H. Epidemiologic Research, Principles and Quantitative Methods. New York: Van Nostrand Reinhold, 1982.
- Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Furnié A et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 416–20.
- De Boer K, Ten Cate JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–100.
- Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 148: 1092–7.
- Sandset PM. Tissue factor pathway inhibitor (TFPI) – an update. Haemostasis 1996; 26 (Suppl 4): 154–65.
- Kemkes-Matthes B. Acquired protein S deficiency. Clin Invest 1992; 70: 529–34.
- Lindoff C, Lecander I, Astedt B. Fibrinolytic components in individual consecutive plasma samples during normal pregnancy. Fibrinolysis 1993; 7: 190–4.
- Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 1991; 66: 410–14.
- Estelles A, Gilabert J, Espafia F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991; 165: 138–42.
- De Boer K, Lecander I, Ten Cate JW, Borm JJJ, Treffers PE. Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 1988; 158: 518–22.
- Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fat acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 614–20.
- Van Den Elzen HJ, Wladimiroff JW, Cohen-Overbeek TE, De Bruijn AJ, Grobbee DE. Serum lipids in early pregnancy and risk of pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 117–22.
- Robbie LA, Booth NA, Croll AM, Bennett B. The roles of α2-antiplasmin and plasminogen activator inhibitor 1 (PAI- 1) in the inhibition of clot lysis. Thromb Haemost 1993; 70: 301–6.
- Laurini R, Laurin J, Marŝàl K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand 1994; 73: 529–34.
- Rössner S, Öhlin A. Maternal body weight and relation to birth weight. Acta Obstet Gynecol Scand 1990; 69: 475–8.